FR2215944A1 - Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies - Google Patents

Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies

Info

Publication number
FR2215944A1
FR2215944A1 FR7303598A FR7303598A FR2215944A1 FR 2215944 A1 FR2215944 A1 FR 2215944A1 FR 7303598 A FR7303598 A FR 7303598A FR 7303598 A FR7303598 A FR 7303598A FR 2215944 A1 FR2215944 A1 FR 2215944A1
Authority
FR
France
Prior art keywords
histaminase
monoamine
free
human placenta
kininases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7303598A
Other languages
French (fr)
Other versions
FR2215944B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Priority to FR7303598A priority Critical patent/FR2215944A1/en
Publication of FR2215944A1 publication Critical patent/FR2215944A1/en
Application granted granted Critical
Publication of FR2215944B1 publication Critical patent/FR2215944B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Therapeutic compsn derived from human placenta comprising alpha 2-macroglobulins carrying histaminase, kininase and monoamine-oxidase, enzyme activity, and free from true protease activity. For treatment of allergies by destruction of allergens such as histamine, kinins serotonin slow-reacting substance'. Prepd by passing dialysed placental extract through a cation-exchanger to remove protein. The protein remaining on the ion-exchanger may be eluted to provide a source of immunoglobulins.
FR7303598A 1973-02-01 1973-02-01 Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies Granted FR2215944A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7303598A FR2215944A1 (en) 1973-02-01 1973-02-01 Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7303598A FR2215944A1 (en) 1973-02-01 1973-02-01 Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies

Publications (2)

Publication Number Publication Date
FR2215944A1 true FR2215944A1 (en) 1974-08-30
FR2215944B1 FR2215944B1 (en) 1976-07-02

Family

ID=9114189

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7303598A Granted FR2215944A1 (en) 1973-02-01 1973-02-01 Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies

Country Status (1)

Country Link
FR (1) FR2215944A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364225A1 (en) * 1976-09-08 1978-04-07 Behringwerke Ag SPECIFIC PROTEIN OF ORGANIC TISSUES AND THEIR PREPARATION PROCESS
WO2001001995A2 (en) * 1999-07-06 2001-01-11 Nutricology, Inc. Method for treatment of asthma syndrome
WO2002043745A2 (en) * 2000-11-29 2002-06-06 Universita' Degli Studi Di Roma 'la Sapienza' Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
WO2006003213A1 (en) * 2004-07-07 2006-01-12 Albert Missbichler Diaminooxidase-containing pharmaceutical compositions
WO2012127381A1 (en) * 2011-03-18 2012-09-27 Dr Healthcare España, S. L. Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
WO2012127392A1 (en) * 2011-03-18 2012-09-27 Dr Healthcare España, S. L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
US9795654B2 (en) 2012-04-18 2017-10-24 Dr Healthcare España, S.L. Diamine oxidase for use in the treatment or prevention of attention deficit hyperactivity disorder (ADHD)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364225A1 (en) * 1976-09-08 1978-04-07 Behringwerke Ag SPECIFIC PROTEIN OF ORGANIC TISSUES AND THEIR PREPARATION PROCESS
WO2001001995A2 (en) * 1999-07-06 2001-01-11 Nutricology, Inc. Method for treatment of asthma syndrome
WO2001001995A3 (en) * 1999-07-06 2001-11-15 Nutricology Inc Method for treatment of asthma syndrome
WO2002043745A2 (en) * 2000-11-29 2002-06-06 Universita' Degli Studi Di Roma 'la Sapienza' Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
WO2002043745A3 (en) * 2000-11-29 2003-04-10 Univ Roma Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
US8722038B2 (en) 2000-11-29 2014-05-13 Bruno Mondovi′ Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
EP1782824A2 (en) 2004-07-07 2007-05-09 Albert Missbichler Diaminooxidase-containing pharmaceutical preparations
EP1782824A3 (en) * 2004-07-07 2007-07-18 Albert Missbichler Diaminooxidase-containing pharmaceutical preparations
AU2005259167B2 (en) * 2004-07-07 2010-06-03 Sciotec Diagnostic Technologies Gmbh Diaminooxidase-containing pharmaceutical compositions
US8716244B2 (en) 2004-07-07 2014-05-06 Sciotec Diagnostic Technologies Gmbh Diaminooxidase-containing pharmaceutical compositions
WO2006003213A1 (en) * 2004-07-07 2006-01-12 Albert Missbichler Diaminooxidase-containing pharmaceutical compositions
US9364437B2 (en) 2004-07-07 2016-06-14 Sciotec Diagnostic Technologies Gmbh Diaminooxidase-containing pharmaceutical compositions
WO2012127381A1 (en) * 2011-03-18 2012-09-27 Dr Healthcare España, S. L. Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
WO2012127392A1 (en) * 2011-03-18 2012-09-27 Dr Healthcare España, S. L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
US9795654B2 (en) 2012-04-18 2017-10-24 Dr Healthcare España, S.L. Diamine oxidase for use in the treatment or prevention of attention deficit hyperactivity disorder (ADHD)

Also Published As

Publication number Publication date
FR2215944B1 (en) 1976-07-02

Similar Documents

Publication Publication Date Title
DE69534130D1 (en) COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH VASCULOGENESIS AND / OR ANGIOGENESIS.
DE69533040D1 (en) MEDICINES FOR PREVENTING OR TREATING VASCULAR HEMORRHAGIA
ATE277612T1 (en) ARYL UREA DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY OR IMMUNOMODULATORY DISEASES
DE297436T1 (en) TREATMENT OF HYPERHIDROSE, ICHTYOSIS AND WRINKLE FORMATION.
NO881657L (en) MEDICAL PREPARATIONS BASED ON OIL MASK EXTRACTS, PROCEDURES FOR THE MANUFACTURING THEREOF AND USE OF OIL MASK EXTRACTS FOR THE PRODUCTION OF COSMETIC PREPARATIONS AND A SPECIAL OIL MASK EXTRACT.
HUP9902698A2 (en) Human bikunin
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE59102667D1 (en) MEANS TO REDUCE GROWTH OR REMOVAL OF HAIR ON HUMAN BODY.
DE3482754D1 (en) MEDICINE AND MEDICINE POSSIBLE COMPOSITION FOR TREATING AND / OR PREVENTING SKIN DISEASES CAUSED BY INFLAMMATION.
AT332561B (en) METHODS FOR TREATMENT OF HAIR, PARTICULARLY DAMAGED HAIR, AND MEANS OF CARRYING OUT THIS PROCEDURE
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
DK130337B (en) Elastic pressure bandage for heat treatment of body parts and method for manufacturing the bandage.
DE3884200T2 (en) Procedures to treat mastitis and other staph infections.
FR2215944A1 (en) Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies
DE68917353D1 (en) N-alkoxyalkylamides of hydroxy acids and skin treatment preparations containing them.
BE778334A (en) IMPROVEMENTS IN THE TREATMENT OF SKIN AND MUCOUS DISEASES
DE58906239D1 (en) Facility for the treatment of diseases, in particular the visual pathway.
AT306895B (en) Preparations for treating injured body tissue
ES294759A1 (en) Processes for the extraction of proteins and other useful constituents contained in vegetable tissues
DE68905076T2 (en) Pharmaceutical composition for the treatment of skin wounds.
FR2201867A1 (en) Chromatographic extraction of urokinase - by treating human urine extract on cellulose deae type resin
IE811612L (en) Thiazoles
NL7503964A (en) ESTABLISHMENT AND METHOD FOR THE ELECTRO-THERAPEUTIC, ESPECIALLY CARCINOMA TREATMENT OF PATIENTS.
FR2181507A1 (en) Animal and vegetable proteolysates prepn - for treatment of undernutrition
FR2014M (en) Medicament for the treatment of eczema and other skin diseases, in particular conditions causing baldness.

Legal Events

Date Code Title Description
ST Notification of lapse